Russian Pharmaceutical Forum 2012
Venue: St. Petersburg
|Event Date/Time: May 22, 2012||End Date/Time: May 24, 2012|
|Early Registration Date: Apr 27, 2012|
Current Business Environment & Key Playersâ€™ Revenue Models: leading players views on the emerging opportunities and growth trends
360Â° Regulatory Review: impact of the recent implementation of Federal Law â„– 61-FZ
Healthcare funding: Is Russia really different from other European countries in its approach to healthcare funding?
Distribution, Wholesale and Retail: leading player updates - overview of challenges and future strategies
Analysing biosimilars: How will they affect the market in the next 3-5 years?
Addressing ethical issues in drug pricing: To what extent is the problem of making drugs more affordable not an issue of price, but of access?
Fuelling sustainable development by effective company & product acquisitions, full exploitation of in-house R&D opportunities and effective in/out-licensing partnerships
Increasing efficiency across marketing and sales activities while enhancing customer focus
Pharmaceutical advocacy & lobbying: Should the industry play a larger role in state and federal government legislation?